Masson P, Lushchekina S (2022)
Conformational Stability and Denaturation Processes of Proteins Investigated by Electrophoresis under Extreme Conditions
Molecules 27:

Mukhametgalieva AR, Lushchekina SV, Aglyamova AR, Masson P (2021)
Steady-state kinetic analysis of human cholinesterases over wide concentration ranges of competing substrates
Biochimica & Biophysica Acta Proteins Proteom

Pashirova TN, Bogdanov A, Masson P (2021)
Therapeutic nanoreactors for detoxification of xenobiotics: Concepts, challenges and biotechnological trends with special emphasis to organophosphate bioscavenging
Chemico-Biological Interactions

Poirier L, Jacquet P, Plener L, Masson P, Daude D, Chabriere E (2021)
Organophosphorus poisoning in animals and enzymatic antidotes
Environ Sci Pollut Res Int 28: 25081

Zueva IV, Lenina OA, Kayumova RM, Petrov KA, Masson P (2021)
Protective effects of m-(tert-butyl) trifluoroacetophenone, a transition state analogue of acetylcholine, against paraoxon toxicity and memory impairments
Chemico-Biological Interactions 345: 109558

Zueva I, Lushchekina S, Shulnikova P, Lenina O, Petrov K, Molochkina E, Masson P (2021)
alpha-tocopherol, a slow-binding inhibitor of acetylcholinesterase
Chemico-Biological Interactions

Lenina OA, Zueva IV, Zobov VV, Semenov VE, Masson P, Petrov KA (2020)
Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning
Sci Rep 10: 16611

Lushchekina SV, Masson P (2020)
Slow-binding inhibitors of acetylcholinesterase of medical interest
Neuropharmacology

Lushchekina SV, Inidjel G, Martinez N, Masson P, Trovaslet-Leroy M, Nachon F, Koza MM, Seydel T, Peters J (2020)
Impact of Sucrose as Osmolyte on Molecular Dynamics of Mouse Acetylcholinesterase
Biomolecules 10:

Zueva IV, Lushchekina SV, Daude D, Chabriere E, Masson P (2020)
Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry
Molecules 25:

Zueva IV, Lushchekina SV, Pottie IR, Darvesh S, Masson P (2020)
1-(3-Tert-Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies
Biomolecules 10:

Grigorenko BL, Novichkova DA, Lushchekina SV, Zueva IV, Schopfer LM, Nemukhin AV, Varfolomeev SD, Lockridge O, Masson P (2019)
Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad
Chemico-Biological Interactions 306: 138

Kangur L, Timpmann K, Zeller D, Masson P, Peters J, Freiberg A (2019)
Structural Stability of Human Butyrylcholinesterase under High Hydrostatic Pressure
Biochimica & Biophysica Acta Proteins Proteom 1867: 107

Mukhametgalieva AR, Zueva IV, Aglyamova AR, Lushchekina SV, Masson P (2019)
A new sensitive spectrofluorimetric method for measurement of activity and kinetic study of cholinesterases
Biochimica & Biophysica Acta Proteins Proteom

Mukhametgalieva AR, Aglyamova AR, Lushchekina SV, Golicnik M, Masson P (2019)
Time-course of human cholinesterases-catalyzed competing substrate kinetics
Chemico-Biological Interactions 310: 108702

Novichkova DA, Lushchekina SV, Dym O, Masson P, Silman I, Sussman JL (2019)
The four-helix bundle in cholinesterase dimers: Structural and energetic determinants of stability
Chemico-Biological Interactions 309: 108699

Semenov VE, Zueva IV, Lushchekina SV, Lenina OA, Gubaidullina LM, Saifina LF, Shulaeva MM, Kayumova RM, Saifina AF, Gubaidullin AT, Kondrashova SA, Latypov SK, Masson P, Petrov KA (2019)
6-Methyluracil derivatives as peripheral site ligand-hydroxamic acid conjugates: Reactivation for paraoxon-inhibited acetylcholinesterase
Eur Journal of Medicinal Chemistry 185: 111787

Zueva IV, Dias J, Lushchekina SV, Semenov VE, Mukhamedyarov MA, Pashirova TN, Babaev VM, Nachon F, Petrova N, Nurullin LF, Zakharova LY, Ilyin VI, Masson P, Petrov KA (2019)
New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease
Neuropharmacology 155: 131

Boyko KM, Baymukhametov TN, Chesnokov YM, Hons M, Lushchekina SV, Konarev PV, Lipkin AV, Vasiliev AL, Masson P, Popov VO, Kovalchuk MV (2018)
3D structure of the natural tetrameric form of human butyrylcholinesterase as revealed by cryoEM, SAXS and MD
Biochimie 156: 196

Lockridge O, David E, Schopfer LM, Masson P, Brazzolotto X, Nachon F (2018)
Purification of recombinant human butyrylcholinesterase on Hupresin(R)
Journal of Chromatography B Analyt Technol Biomed Life Sciences 1102-1103: 109

Lushchekina SV, Schopfer LM, Grigorenko BL, Nemukhin AV, Varfolomeev SD, Lockridge O, Masson P (2018)
Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents
Front Pharmacol 9: 211

Lushchekina S, Masson P (2018)
Catalytic bioscavengers against organophosphorus agents: mechanistic issues of self-reactivating cholinesterases
Toxicology 409: 91

Pashirova TN, Zueva IV, Petrov KA, Lukashenko SS, Nizameev IR, Kulik NV, Voloshina AD, Almasy L, Kadirov MK, Masson P, Souto EB, Zakharova LY, Sinyashin OG (2018)
Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model
Colloids Surf B Biointerfaces 171: 358

Pashirova TN, Braiki A, Zueva IV, Petrov KA, Babaev VM, Burilova EA, Samarkina DA, Rizvanov IK, Souto EB, Jean L, Renard PY, Masson P, Zakharova LY, Sinyashin OG (2018)
Combination delivery of two oxime-loaded lipid nanoparticles: Time-dependent additive action for prolonged rat brain protection
J Control Release 290: 102

Petrov KA, Zueva IV, Kovyazina IV, Sedov I, Lushchekina SV, Kharlamova AD, Lenina O, Koshkin S, Shtyrlin Y, Nikolsky EE, Masson P (2018)
C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies
Neuropharmacology 131: 304

Petrov KA, Nikolsky EE, Masson P (2018)
Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes
Front Pharmacol 9: 766

Zueva IV, Lushchekina SV, Masson P (2018)
Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase
Bioscience Reports 38:

Dafferner AJ, Lushchekina SV, Masson P, Xiao G, Schopfer LM, Lockridge O (2017)
Characterization of butyrylcholinesterase in bovine serum
Chemico-Biological Interactions 266: 17

Masson P, Nachon F (2017)
Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning
Journal of Neurochemistry 142 Suppl 2: 26

Pashirova TN, Zueva IV, Petrov KA, Babaev VM, Lukashenko SS, Rizvanov IK, Souto EB, Nikolsky EE, Zakharova LY, Masson P, Sinyashin OG (2017)
Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity
ACS Appl Mater Interfaces 9: 16922

Schopfer LM, Delacour H, Masson P, Leroy J, Krejci E, Lockridge O (2017)
The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment
Molecules 22:

Terekhov SS, Smirnov IV, Stepanova AV, Bobik TV, Mokrushina YA, Ponomarenko NA, Belogurov AA, Jr., Rubtsova MP, Kartseva OV, Gomzikova MO, Moskovtsev AA, Bukatin AS, Dubina MV, Kostryukova ES, Babenko VV, Vakhitova MT, Manolov AI, Malakhova MV, Kornienko MA, Tyakht AV, Vanyushkina AA, Ilina EN, Masson P, Gabibov AG, Altman S (2017)
Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity
Proc Natl Acad Sci U S A 114: 2550

Terekhov SS, Palikov VA, Palikova YA, Dyachenko IA, Shamborant OG, Smirnov IV, Masson P, Gabibov AG (2017)
Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate Poisoning
Bulletin of Experimental Biology & Medicine 163: 430

Elistratova JG, Mustafina AR, Brylev KA, Petrov KA, Shestopalov MA, Mironov YV, Babaev VM, Rizvanov IK, Masson P, Sinyashin OG (2016)
Sensing activity of cholinesterases through a luminescence response of the hexarhenium cluster complex [{Re6S8}(OH)6](4.)
Analyst 141: 4204

Jacquet P, Daude D, Bzdrenga J, Masson P, Elias M, Chabriere E (2016)
Current and emerging strategies for organophosphate decontamination: special focus on hyperstable enzymes
Environ Sci Pollut Res Int 23: 8200

Kharlamova AD, Lushchekina SV, Petrov KA, Kots ED, Nachon F, Villard-Wandhammer M, Zueva IV, Krejci E, Reznik VS, Zobov VV, Nikolsky EE, Masson P (2016)
Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment
Biochemical Journal 473: 1225

Lushchekina SV, Nemukhin AV, Varfolomeev SD, Masson P (2016)
Understanding the non-catalytic behavior of human butyrylcholinesterase silent variants: comparison of wild-type enzyme, catalytically active Ala328Cys mutant, and silent Ala328Asp variant
Chemico-Biological Interactions 259: 223

Masson P, Lushchekina SV (2016)
Emergence of catalytic bioscavengers against organophosphorus agents
Chemico-Biological Interactions 259: 319

Peng H, Brimijoin S, Hrabovska A, Krejci E, Blake TA, Johnson RC, Masson P, Lockridge O (2016)
Monoclonal antibodies to human butyrylcholinesterase reactive with butyrylcholinesterase in animal plasma
Chemico-Biological Interactions 243: 82

Peters J, Martinez N, Trovaslet M, Scannapieco K, Koza MM, Masson P, Nachon F (2016)
Dynamics of human acetylcholinesterase bound to non-covalent and covalent inhibitors shedding light on changes to the water network structure
Phys Chem Chem Phys 18: 12992

Lushchekina SV, Delacour H, Lockridge O, Masson P (2015)
Human butyrylcholinesterase polymorphism: Molecular modeling
Int J Risk Saf Med 27 Suppl 1: S80

Lushchekina SV, Kots ED, Kharlamova AD, Petrov KA, Masson P (2015)
Molecular modeling of mechanism of action of anti-myasthenia gravis slow-binding inhibitor of acetylcholinesterase
Int J Risk Saf Med 27 Suppl 1: S74

Marion J, Trovaslet M, Martinez N, Masson P, Schweins R, Nachon F, Trapp M, Peters J (2015)
Pressure-induced molten globule state of human acetylcholinesterase: structural and dynamical changes monitored by neutron scattering
Phys Chem Chem Phys 17: 3157

Mukhametshina AR, Fedorenko SV, Zueva IV, Petrov KA, Masson P, Nizameev IR, Mustafina AR, Sinyashin OG (2015)
Luminescent silica nanoparticles for sensing acetylcholinesterase-catalyzed hydrolysis of acetylcholine
Biosensors & Bioelectronics 77: 871

Peng H, Brimijoin S, Hrabovska A, Targosova K, Krejci E, Blake TA, Johnson RC, Masson P, Lockridge O (2015)
Comparison of 5 monoclonal antibodies for immunopurification of human butyrylcholinesterase on Dynabeads: K values, binding pairs, and amino acid sequences
Chemico-Biological Interactions 240: 336

Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS (2015)
6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease
ChemMedChem 10: 1863

Terekhov SS, Smirnov IV, Bobik TV, Shamborant OG, Zenkova MA, Chernolovskaya EL, Gladkikh DV, Murashev AN, Dyachenko IA, Palikov VA, Palikova YA, Knorre VD, Belogurov AA, Jr., Ponomarenko NA, Blackburn GM, Masson P, Gabibov AG (2015)
A novel expression cassette delivers efficient production of exclusively tetrameric human butyrylcholinesterase with improved pharmacokinetics for protection against organophosphate poisoning
Biochimie 118: 51

Terekhov SS, Smirnov IV, Shamborant OG, Bobik TV, Ilyushin DG, Murashev AN, Dyachenko IA, Palikov VA, Knorre VD, Belogurov AA, Ponomarenko NA, Kuzina ES, Genkin DD, Masson P, Gabibov AG (2015)
Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers
Acta Naturae 7: 136

Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS (2015)
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease
Int J Risk Saf Med 27 Suppl 1: S69

Delacour H, Lushchekina SV, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, Lockridge O, Masson P (2014)
Characterization of a Novel BCHE Silent Allele: Point Mutation (p.Val204Asp) Causes Loss of Activity and Prolonged Apnea with Suxamethonium
PLoS ONE 9: e101552

Delacour H, Lushchekina SV, Mabboux I, Ceppa F, Masson P, Schopfer LM, Lockridge O (2014)
Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), silent with mivacurium
Biochemical Pharmacology 92: 476

Lushchekina SV, Nemukhin AV, Varfolomeev SD, Masson P (2014)
Molecular Modeling Evidence for His438 Flip in the Mechanism of Butyrylcholinesterase Hysteretic Behavior
Journal of Molecular Neuroscience 52: 434

Schopfer LM, Masson P, Lamourette P, Simon S, Lockridge O (2014)
Detection of cresyl phosphate-modified butyrylcholinesterase in human plasma for chemical exposure associated with aerotoxic syndrome
Analytical Biochemistry 461C: 17

Trapp M, Tehei M, Trovaslet M, Nachon F, Martinez N, Koza MM, Weik M, Masson P, Peters J (2014)
Correlation of the dynamics of native human acetylcholinesterase and its inhibited huperzine A counterpart from sub-picoseconds to nanoseconds
J R Soc Interface 11:

Carletti E, Colletier JP, Schopfer LM, Santoni G, Masson P, Lockridge O, Nachon F, Weik M (2013)
Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry
Chemical Research in Toxicology 26: 280

Ilyushin DG, Smirnov IV, Belogurov AA, Jr., Dyachenko IA, Zharmukhamedova T, Novozhilova TI, Bychikhin EA, Serebryakova MV, Kharybin ON, Murashev AN, Anikienko KA, Nikolaev EN, Ponomarenko NA, Genkin DD, Blackburn GM, Masson P, Gabibov AG (2013)
Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo
Proc Natl Acad Sci U S A 110: 1243

Ilyushin DG, Haertley OM, Bobik TV, Shamborant OG, Surina EA, Knorre VD, Masson P, Smirnov IV, Gabibov AG, Ponomarenko NA (2013)
Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system
Acta Naturae 5: 73

Jiang W, Cashman JR, Nachon F, Masson P, Schopfer LM, Lockridge O (2013)
Mass spectrometry method to identify aging pathways of Sp- and Rp-tabun adducts on human butyrylcholinesterase based on the acid labile P-N bond
Toxicol Sci 132: 390

Jiang W, Murashko EA, Dubrovskii YA, Podolskaya EP, Babakov VN, Mikler J, Nachon F, Masson P, Schopfer LM, Lockridge O (2013)
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase
Analytical Biochemistry 439: 132

Jiang W, Dubrovskii YA, Podolskaya EP, Murashko EA, Babakov VN, Nachon F, Masson P, Schopfer LM, Lockridge O (2013)
PHOS-Select Iron Affinity Beads Enrich Peptides for the Detection of Organophosphorus Adducts on Albumin
Chemical Research in Toxicology 26: 1917

Li B, Duysen EG, Froment MT, Masson P, Nachon F, Jiang W, Schopfer LM, Thiele GM, Klassen LW, Cashman JR, Williams GR, Lockridge O (2013)
Polyclonal antibody to soman-tyrosine
Chemical Research in Toxicology 26: 584

Lushchekina SV, Masson P, Rosenberry TL (2013)
This special Issue of Chemico-Biological Interactions comprises 70 manuscripts from lectures and short talks given at the 11th International Meeting on Cholinesterases. Preface
Chemico-Biological Interactions 203: 1

Masson P, Lushchekina SV, Schopfer LM, Lockridge O (2013)
Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies
Biochemical Journal 454: 387

Nachon F, Brazzolotto X, Trovaslet M, Masson P (2013)
Progress in the development of enzyme-based nerve agent bioscavengers
Chemico-Biological Interactions 206: 536

Rozengart EV, Basova NE, Moralev SN, Lushchekina SV, Masson P, Varfolomeev SD (2013)
Research on cholinesterases in the Soviet Union and Russia: a historical perspective
Chemico-Biological Interactions 203: 3

Smirnov IV, Belogurov AA, Jr., Friboulet A, Masson P, Gabibov AG, Renard PY (2013)
Strategies for the selection of catalytic antibodies against organophosphorus nerve agents
Chemico-Biological Interactions 203: 196

Trovaslet M, Trapp M, Weik M, Nachon F, Masson P, Tehei M, Peters J (2013)
Relation between dynamics, activity and thermal stability within the cholinesterase family
Chemico-Biological Interactions 203: 14

Duysen EG, Cashman JR, Schopfer LM, Nachon F, Masson P, Lockridge O (2012)
Differential sensitivity of plasma carboxylesterase-null mice to parathion, chlorpyrifos and chlorpyrifos oxon, but not to diazinon, dichlorvos, diisopropylfluorophosphate, cresyl saligenin phosphate, cyclosarin thiocholine, tabun thiocholine, and carbofuran
Chemico-Biological Interactions 195: 189

Masson P (2012)
Time-dependent kinetic complexities in cholinesterase-catalyzed reactions
Biochemistry (Mosc) 77: 1147

Peters J, Trovaslet M, Trapp M, Nachon F, Hill F, Royer E, Gabel F, van Eijck L, Masson P, Tehei M (2012)
Activity and molecular dynamics relationship within the family of human cholinesterases
Phys Chem Chem Phys 14: 6764

Rosenbaum E, Gabel F, Dura MA, Finet S, Clery-Barraud C, Masson P, Franzetti B (2012)
Effects of hydrostatic pressure on the quaternary structure and enzymatic activity of a large peptidase complex from Pyrococcus horikoshii
Archives of Biochemistry & Biophysics 517: 104

Trapp M, Trovaslet M, Nachon F, Koza MM, van Eijck L, Hill F, Weik M, Masson P, Tehei M, Peters J (2012)
Energy landscapes of human acetylcholinesterase and its huperzine a-inhibited counterpart
J Phys Chem B 116: 14744

Carletti E, Schopfer LM, Colletier JP, Froment MT, Nachon F, Weik M, Lockridge O, Masson P (2011)
Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis
Chemical Research in Toxicology 24: 797

Liyasova M, Li B, Schopfer LM, Nachon F, Masson P, Furlong CE, Lockridge O (2011)
Exposure to tri-o-cresyl phosphate detected in jet airplane passengers
Toxicol Appl Pharmacol 256: 337

Masson P (2011)
Evolution of and perspectives on therapeutic approaches to nerve agent poisoning
Toxicol Lett 206: 5

Nachon F, Carletti E, Wandhammer M, Nicolet Y, Schopfer LM, Masson P, Lockridge O (2011)
X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger
Biochemical Journal 434: 73

Smirnov IV, Carletti E, Kurkova I, Nachon F, Nicolet Y, Mitkevich VA, Debat H, Avalle B, Belogurov AA, Jr., Kuznetsov N, Reshetnyak A, Masson P, Tonevitsky AG, Ponomarenko NA, Makarov AA, Friboulet A, Tramontano A, Gabibov AG (2011)
Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics
Proc Natl Acad Sci U S A 108: 15954

Trovaslet-Leroy M, Musilova L, Renault F, Brazzolotto X, Misik J, Novotny L, Froment MT, Gillon E, Loiodice M, Verdier L, Masson P, Rochu D, Jun D, Nachon F (2011)
Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents
Toxicol Lett 206: 14

Wandhammer M, Carletti E, van der Schans M, Gillon E, Nicolet Y, Masson P, Goeldner M, Noort D, Nachon F (2011)
Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents
Journal of Biological Chemistry 286: 16783

Carletti E, Colletier JP, Dupeux F, Trovaslet M, Masson P, Nachon F (2010)
Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation
Journal of Medicinal Chemistry 53: 4002

Jun D, Musilova L, Link M, Loiodice M, Nachon F, Rochu D, Renault F, Masson P (2010)
Preparation and characterization of methoxy polyethylene glycol-conjugated phosphotriesterase as a potential catalytic bioscavenger against organophosphate poisoning
Chemico-Biological Interactions 187: 380

Li B, Ricordel I, Schopfer LM, Baud F, Megarbane B, Masson P, Lockridge O (2010)
Dichlorvos, chlorpyrifos oxon and Aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose
J Appl Toxicol 30: 559

Li B, Ricordel I, Schopfer LM, Baud F, Megarbane B, Nachon F, Masson P, Lockridge O (2010)
Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos
Toxicol Sci 116: 23

Masson P, Lockridge O (2010)
Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior
Archives of Biochemistry & Biophysics 494: 107

Masson P, Nachon F, Lockridge O (2010)
Structural approach to the aging of phosphylated cholinesterases
Chemico-Biological Interactions 187: 157

Nachon F, Carletti E, Worek F, Masson P (2010)
Aging mechanism of butyrylcholinesterase inhibited by an N-methyl analogue of tabun: implications of the trigonal-bipyramidal transition state rearrangement for the phosphylation or reactivation of cholinesterases
Chemico-Biological Interactions 187: 44

Renault F, Carus T, Clery-Barraud C, Elias M, Chabriere E, Masson P, Rochu D (2010)
Integrative analytical approach by capillary electrophoresis and kinetics under high pressure optimized for deciphering intrinsic and extrinsic cofactors that modulate activity and stability of human paraoxonase (PON1)
Journal of Chromatography B Analyt Technol Biomed Life Sciences 878: 1346

Schopfer LM, Grigoryan H, Li B, Nachon F, Masson P, Lockridge O (2010)
Mass spectral characterization of organophosphate-labeled, tyrosine-containing peptides: characteristic mass fragments and a new binding motif for organophosphates
Journal of Chromatography B Analyt Technol Biomed Life Sciences 878: 1297

Tormos JR, Wiley KL, Wang Y, Fournier D, Masson P, Nachon F, Quinn DM (2010)
Accumulation of tetrahedral intermediates in cholinesterase catalysis: a secondary isotope effect study
Journal of the American Chemical Society 132: 17751

Trovaslet-Leroy M, Jolivalt C, Froment MT, Brasme B, Lefebvre B, Daveloose D, Nachon F, Masson P (2010)
Application of laccase-mediator system (LMS) for the degradation of organophosphorus compounds
Chemico-Biological Interactions 187: 393

Carletti E, Aurbek N, Gillon E, Loiodice M, Nicolet Y, Fontecilla-Camps JC, Masson P, Thiermann H, Nachon F, Worek F (2009)
Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Biochemical Journal 421: 97

Gabel F, Masson P, Froment MT, Doctor BP, Saxena A, Silman I, Zaccai G, Weik M (2009)
Direct correlation between molecular dynamics and enzymatic stability: a comparative neutron scattering study of native human butyrylcholinesterase and its aged soman conjugate
Biophysical Journal 96: 1489

Li B, Schopfer LM, Grigoryan H, Thompson CM, Hinrichs SH, Masson P, Lockridge O (2009)
Tyrosines of human and mouse transferrin covalently labeled by organophosphorus agents: a new motif for binding to proteins that have no active site serine
Toxicol Sci 107: 144

Li H, Ricordel I, Tong L, Schopfer LM, Baud F, Megarbane B, Maury E, Masson P, Lockridge O (2009)
Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum
J Appl Toxicol 29: 149

Masson P, Carletti E, Nachon F (2009)
Structure, activities and biomedical applications of human butyrylcholinesterase
Protein Pept Lett 16: 1215

Sanson B, Nachon F, Colletier JP, Froment MT, Toker L, Greenblatt HM, Sussman JL, Ashani Y, Masson P, Silman I, Weik M (2009)
Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime
Journal of Medicinal Chemistry 52: 7593

Badiou A, Froment MT, Fournier D, Masson P, Belzunces LP (2008)
Hysteresis of insect acetylcholinesterase
Chemico-Biological Interactions 175: 410

Carletti E, Li H, Li B, Ekstrom F, Nicolet Y, Loiodice M, Gillon E, Froment MT, Lockridge O, Schopfer LM, Masson P, Nachon F (2008)
Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation
Journal of the American Chemical Society 130: 16011

Ding SJ, Carr J, Carlson JE, Tong L, Xue W, Li Y, Schopfer LM, Li B, Nachon F, Asojo OA, Thompson CM, Hinrichs SH, Masson P, Lockridge O (2008)
Five tyrosines and two serines in human albumin are labeled by the organophosphorus agent FP-biotin
Chemical Research in Toxicology 21: 1787

Dorandeu F, Foquin A, Briot R, Delacour C, Denis J, Alonso A, Froment MT, Renault F, Lallement G, Masson P (2008)
An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX
Toxicology 248: 151

Elias M, Dupuy J, Merone L, Mandrich L, Porzio E, Moniot S, Rochu D, Lecomte C, Rossi M, Masson P, Manco G, Chabriere E (2008)
Structural basis for natural lactonase and promiscuous phosphotriesterase activities
Journal of Molecular Biology 379: 1017

Grigoryan H, Schopfer LM, Thompson CM, Terry AV, Masson P, Lockridge O (2008)
Mass spectrometry identifies covalent binding of soman, sarin, chlorpyrifos oxon, diisopropyl fluorophosphate, and FP-biotin to tyrosines on tubulin: a potential mechanism of long term toxicity by organophosphorus agents
Chemico-Biological Interactions 175: 180

Li B, Nachon F, Froment MT, Verdier L, Debouzy JC, Brasme B, Gillon E, Schopfer LM, Lockridge O, Masson P (2008)
Binding and hydrolysis of soman by human serum albumin
Chemical Research in Toxicology 21: 421

Li H, Schopfer LM, Masson P, Lockridge O (2008)
Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers
Biochemical Journal 411: 425

Li H, Tong L, Schopfer LM, Masson P, Lockridge O (2008)
Fast affinity purification coupled with mass spectrometry for identifying organophosphate labeled plasma butyrylcholinesterase
Chemico-Biological Interactions 175: 68

Lockridge O, Xue W, Gaydess A, Grigoryan H, Ding SJ, Schopfer LM, Hinrichs SH, Masson P (2008)
Pseudo-esterase activity of human albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines
Journal of Biological Chemistry 283: 22582

Masson P, Nachon F, Broomfield CA, Lenz DE, Verdier L, Schopfer LM, Lockridge O (2008)
A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters
Chemico-Biological Interactions 175: 273

Masson P, Froment MT, Gillon E, Nachon F, Lockridge O, Schopfer LM (2008)
Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters
Febs J 275: 2617

Colletier JP, Royant A, Specht A, Sanson B, Nachon F, Masson P, Zaccai G, Sussman JL, Goeldner M, Silman I, Bourgeois D, Weik M (2007)
Use of a 'caged' analogue to study the traffic of choline within acetylcholinesterase by kinetic crystallography
Acta Crystallographica D Biol Crystallogr 63: 1115

Li B, Schopfer LM, Hinrichs SH, Masson P, Lockridge O (2007)
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay for organophosphorus toxicants bound to human albumin at Tyr411
Analytical Biochemistry 361: 263

Li H, Schopfer LM, Nachon F, Froment MT, Masson P, Lockridge O (2007)
Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry
Toxicol Sci 100: 136

Masson P, Froment MT, Darvesh S, Schopfer LM, Lockridge O (2007)
Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate
J Enzyme Inhib Med Chem 22: 463

Masson P, Froment MT, Gillon E, Nachon F, Lockridge O, Schopfer LM (2007)
Hydrolysis of oxo- and thio-esters by human butyrylcholinesterase
Biochimica & Biophysica Acta 1774: 16

Masson P, Froment MT, Gillon E, Nachon F, Darvesh S, Schopfer LM (2007)
Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides
Biochimica & Biophysica Acta 1774: 1139

Rochu D, Chabriere E, Renault F, Elias M, Clery-Barraud C, Masson P (2007)
Stabilization of the active form(s) of human paraoxonase by human phosphate-binding protein
Biochemical Society Transactions 35: 1616

Hrabovska A, Debouzy JC, Froment MT, Devinsky F, Paulikova I, Masson P (2006)
Rat butyrylcholinesterase-catalysed hydrolysis of N-alkyl homologues of benzoylcholine
Febs J 273: 1185

Masurier N, Estour F, Lefevre B, Brasme B, Masson P, Lafont O (2006)
Improved access to 2-O-monobenzyl ethers of beta-cyclodextrin as precursors of catalysts for organophosphoryl esters hydrolysis
Carbohydr Res 341: 935

Poyot T, Nachon F, Froment MT, Loiodice M, Wieseler S, Schopfer LM, Lockridge O, Masson P (2006)
Mutant of Bungarus fasciatus acetylcholinesterase with low affinity and low hydrolase activity toward organophosphorus esters
Biochimica & Biophysica Acta 1764: 1470

Rochu D, Clery-Barraud C, Renault F, Chevalier A, Bon C, Masson P (2006)
Capillary electrophoresis versus differential scanning calorimetry for the analysis of free enzyme versus enzyme-ligand complexes: in the search of the ligand-free status of cholinesterases
Electrophoresis 27: 442

Gabel F, Weik M, Masson P, Renault F, Fournier D, Brochier L, Doctor BP, Saxena A, Silman I, Zaccai G (2005)
Effects of soman inhibition and of structural differences on cholinesterase molecular dynamics: a neutron scattering study
Biophysical Journal 89: 3303

Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O (2005)
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
Biochemical Pharmacology 70: 1673

Marchal S, Torrent J, Masson P, Kornblatt JM, Tortora P, Fusi P, Lange R, Balny C (2005)
The powerful high pressure tool for protein conformational studies
Brazilian Journal of Medical & Biological Research 38: 1175

Masson P, Schopfer LM, Froment MT, Debouzy JC, Nachon F, Gillon E, Lockridge O, Hrabovska A, Goldstein BN (2005)
Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics
Chemico-Biological Interactions 157-158: 143

Masurier N, Estour F, Froment MT, Lefevre B, Debouzy JC, Brasme B, Masson P, Lafont O (2005)
Synthesis of 2-substituted beta-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon
Eur Journal of Medicinal Chemistry 40: 615

Nachon F, Asojo OA, Borgstahl GE, Masson P, Lockridge O (2005)
Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging
Biochemistry 44: 1154

Nachon F, Nicolet Y, Masson P (2005)
[Butyrylcholinesterase: 3D structure, catalytic mechanisms]
Ann Pharm Fr 63: 194

Nachon F, Asojo OA, Borgstahl GE, Masson P, Lockridge O (2005)
Structural data on the aging of diethylphosphoryl-butyrylcholinesterase
Chemico-Biological Interactions 157-158: 408

Tormos JR, Wiley KL, Seravalli J, Nachon F, Masson P, Nicolet Y, Quinn DM (2005)
The reactant state for substrate-activated turnover of acetylthiocholine by butyrylcholinesterase is a tetrahedral intermediate
Journal of the American Chemical Society 127: 14538

Gabel F, Weik M, Doctor BP, Saxena A, Fournier D, Brochier L, Renault F, Masson P, Silman I, Zaccai G (2004)
The influence of solvent composition on global dynamics of human butyrylcholinesterase powders: a neutron-scattering study
Biophysical Journal 86: 3152

Masson P, Goldstein BN, Debouzy JC, Froment MT, Lockridge O, Schopfer LM (2004)
Damped oscillatory hysteretic behaviour of butyrylcholinesterase with benzoylcholine as substrate
European Journal of Biochemistry 271: 220

Masson P, Froment MT, Nachon F, Schopfer LM (2004)
Hysteresis in butyrylcholinesterase catalysis.
Cholinergic Mechanisms, CRC Press

Masson P, Froment MT, Nachon F, Lockridge O, Schopfer LM (2004)
Hysteretic behavior of butyrylcholinesterase: Kinetic curiosity or catalytically and physiologicaly significant?
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 191

Masson P, Bec N, Froment MT, Nachon F, Balny C, Lockridge O, Schopfer LM (2004)
Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior
European Journal of Biochemistry 271: 1980

Masson P, Froment MT, Nachon F, Lockridge O, Schopfer LM (2004)
Poster (20) Hysteretic behavior of butyrylcholinesterase : kinetic curiosity or catalytically and physiologically significant?
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 331

Nachon F, Nicolet Y, Masson P, Lockridge O, Fontecilla-Camps JC (2004)
X-Ray structures of native and soman-aged human butyrylcholinesterase.
Cholinergic Mechanisms, CRC Press

Nachon F, Nicolet Y, Masson P, Lockridge O, Fontecilla-Camps JC (2004)
Poster (93) How do the crystal structures of human butyrylcholinesterase compare to torpedo californica acetylcholinesterases structures?
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 369

Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F (2004)
Poster (49) Crystallographic basis for substrate/product exchange in cholinesterases.
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 347

Rochu D, Viguie N, Renault F, Crouzier D, Froment MT, Masson P (2004)
Contribution of the active-site metal cation to the catalytic activity and to the conformational stability of phosphotriesterase: temperature- and pH-dependence
Biochemical Journal 380: 627

Rochu D, Renault F, Bon C, Masson P (2004)
Capillary zone electrophoresis detects unwanted cholinesterase-bound hidden ligands that alter enzyme conformational stability.
Cholinergic Mechanisms, CRC Press

Wang Y, Schopfer LM, Duysen EG, Nachon F, Masson P, Lockridge O (2004)
Screening assays for cholinesterases resistant to inhibition by organophosphorus toxicants
Analytical Biochemistry 329: 131

Loudwig S, Nicolet Y, Masson P, Fontecilla-Camps JC, Bon S, Nachon F, Goeldner M (2003)
Photoreversible inhibition of cholinesterases: catalytic serine-labeled caged butyrylcholinesterase
Chembiochem 4: 762

Masson P, Nachon F, Bartels CF, Froment MT, Ribes F, Matthews C, Lockridge O (2003)
High activity of human butyrylcholinesterase at low pH in the presence of excess butyrylthiocholine
European Journal of Biochemistry 270: 315

Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F (2003)
Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products
Journal of Biological Chemistry 278: 41141

Clery-Barraud C, Ordentlich A, Grosfeld H, Shafferman A, Masson P (2002)
Pressure and heat inactivation of recombinant human acetylcholinesterase. Importance of residue E202 for enzyme stability
European Journal of Biochemistry 269: 4297

Masson P, Froment MT, Fort S, Ribes F, Bec N, Balny C, Schopfer LM (2002)
Butyrylcholinesterase-catalyzed hydrolysis of N-methylindoxyl acetate: analysis of volume changes upon reaction and hysteretic behavior
Biochimica & Biophysica Acta 1597: 229

Masson P, Schopfer LM, Bartels CF, Froment MT, Ribes F, Nachon F, Lockridge O (2002)
Substrate activation in acetylcholinesterase induced by low pH or mutation in the pi-cation subsite
Biochimica & Biophysica Acta 1594: 313

Nachon F, Nicolet Y, Viguie N, Masson P, Fontecilla-Camps JC, Lockridge O (2002)
Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization
European Journal of Biochemistry 269: 630

Rochu D, Renault F, Masson P (2002)
Detection of unwanted protein-bound ligands by capillary zone electrophoresis: the case of hidden ligands that stabilize cholinesterase conformation
Electrophoresis 23: 930

Stojan J, Golicnik M, Froment MT, Estour F, Masson P (2002)
Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion
European Journal of Biochemistry 269: 1154

Josse D, Lockridge O, Xie W, Bartels CF, Schopfer LM, Masson P (2001)
The active site of human paraoxonase (PON1)
J Appl Toxicol 21 Suppl 1: S7

Masson P, Xie W, Froment MT, Lockridge O (2001)
Effects of mutations of active site residues and amino acids interacting with the Omega loop on substrate activation of butyrylcholinesterase
Biochimica & Biophysica Acta 1544: 166

Rochu D, Pernet T, Renault F, Bon C, Masson P (2001)
Dual effect of high electric field in capillary electrophoresis study of the conformational stability of Bungarus fasciatus acetylcholinesterase
Journal of Chromatography A 910: 347

Rochu D, Georges C, Repiton J, Viguie N, Saliou B, Bon C, Masson P (2001)
Thermal stability of acetylcholinesterase from Bungarus fasciatus venom as investigated by capillary electrophoresis
Biochimica & Biophysica Acta 1545: 216

Weingand-Ziade A, Ribes F, Renault F, Masson P (2001)
Pressure- and heat-induced inactivation of butyrylcholinesterase: evidence for multiple intermediates and the remnant inactivation process
Biochemical Journal 356: 487

Lockridge O, Masson P (2000)
Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk
Neurotoxicology 21: 113

Josse D, Xie W, Renault F, Rochu D, Schopfer LM, Masson P, Lockridge O (1999)
Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities
Biochemistry 38: 2816

Josse D, Xie W, Masson P, Lockridge O (1999)
Human serum paraoxonase (PON1): identification of essential amino acid residues by group-selective labelling and site-directed mutagenesis
Chemico-Biological Interactions 119-120: 71

Josse D, Xie W, Masson P, Schopfer LM, Lockridge O (1999)
Tryptophan residue(s) as major components of the human serum paraoxonase active site
Chemico-Biological Interactions 119-120: 79

Levitsky V, Xie W, Froment MT, Lockridge O, Masson P (1999)
Polyol-induced activation by excess substrate of the D70G butyrylcholinesterase mutant
Biochimica & Biophysica Acta 1429: 422

Masson P, Fortier PL, Albaret C, Clery C, Guerra P, Lockridge O (1999)
Structural and hydration changes in the active site gorge of phosporhylated butyrylcholinesterase accompanying the aging process
Chemico-Biological Interactions 119-120: 17

Masson P, Xie W, Froment MT, Levitsky V, Fortier PL, Albaret C, Lockridge O (1999)
Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates
Biochimica & Biophysica Acta 1433: 281

Masson P, Clery C, Guerra P, Redslob A, Albaret C, Fortier PL (1999)
Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures
Biochemical Journal 343: 361

Pilotaz F, Masson P (1999)
[Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential]
Ann Pharm Fr 57: 363

Weingand-Ziade A, Renault F, Masson P (1999)
Differential effect of pressure and temperature on the catalytic behaviour of wild-type human butyrylcholinesterase and its D70G mutant
European Journal of Biochemistry 264: 327

Albaret C, Masson P, Broomfield CA, Kaim LE, Fortier PL (1998)
Mechanical Aspects of the Phosphotriesterase Activity of Human Butyrylcholinesterase G117H Mutant
In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases (Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp.: 399

Albaret C, Masson P, Broomfield CA, Kaim LE, Fortier PL (1998)
Poster: Mechanical Aspects of the Phosphotriesterase Activity of Human Butyrylcholinesterase G117H Mutant
In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases (Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp.: 434

Froment MT, Lockridge O, Masson P (1998)
Resistance of butyrylcholinesterase to inactivation by ultrasound: effects of ultrasound on catalytic activity and subunit association
Biochimica & Biophysica Acta 1387: 53

Froment MT, Clery C, Weingand-Ziade A, Masson P (1998)
Stability of the Quaternary Structure of Butyrylcholinesterase Subjected to Ultrasound or Hydrostatic Pressure
In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases (Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp.: 436

Marcel V, Palacios LG, Pertuy C, Masson P, Fournier D (1998)
Two invertebrate acetylcholinesterases show activation followed by inhibition with substrate concentration
Biochemical Journal 329: 329

Masson P, Froment MT, Fortier PL, Visicchio JE, Bartels CF, Lockridge O (1998)
Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters
Biochimica & Biophysica Acta 1387: 41

Masson P, Clery C, Guerra P, Fortier PL, Albaret C, Lockridge O (1998)
Structural Changes in the Active Site Gorge of Phosphylated Cholinesterase Accompanying the Aging Process
In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases (Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp.: 419

Masson P, Josse D, Lockridge O, Viguie N, Taupin C, Buhler C (1998)
Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning
Journal de Physiologie (Paris) 92: 357

Polyzou A, Froment MT, Masson P, Belzunces LP (1998)
Shielding of Acetylcholinesterase does not Result in the Protection of Honey Bee against Poisoning by Organophosphates
In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases (Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp.: 552

Polyzou A, Froment MT, Masson P, Belzunces LP (1998)
Absence of a protective effect of the oxime 2-PAM toward paraoxon-poisoned honey bees: acetylcholinesterase reactivation not at fault
Toxicol Appl Pharmacol 152: 184

Rochu D, Rothlisberger C, Taupin C, Renault F, Gagnon J, Masson P (1998)
Purification, molecular characterization and catalytic properties of a Pseudomonas fluorescens enzyme having cholinesterase-like activity
Biochimica & Biophysica Acta 1385: 126

Stojan J, Marcel V, Estrada-Mondaca S, Klaebe A, Masson P, Fournier D (1998)
A putative kinetic model for substrate metabolisation by Drosophila acetylcholinesterase
FEBS Letters 440: 85

Lockridge O, Blong RM, Masson P, Froment MT, Millard CB, Broomfield CA (1997)
A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase
Biochemistry 36: 786

Masson P, Legrand P, Bartels CF, Froment MT, Schopfer LM, Lockridge O (1997)
Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase
Biochemistry 36: 2266

Masson P, Fortier PL, Albaret C, Froment MT, Bartels CF, Lockridge O (1997)
Aging of di-isopropyl-phosphorylated human butyrylcholinesterase
Biochemical Journal 327 ( Pt 2): 601

Masson P, Froment MT, Bartels CF, Lockridge O (1997)
Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase
Biochemical Journal 325: 53

Weingand-Ziade A, Renault F, Masson P (1997)
Combined pressure/heat-induced inactivation of butyrylcholinesterase
Biochimica & Biophysica Acta 1340: 245

Masson P, Froment MT, Bartels CF, Lockridge O (1996)
Asp7O in the peripheral anionic site of human butyrylcholinesterase
European Journal of Biochemistry 235: 36

Aslanian D, Grof P, Renault F, Masson P (1995)
Raman spectroscopic study of conjugates of butyrylcholinesterase with organophosphates
Biochimica & Biophysica Acta 1249: 37

Blong RM, Masson P, Lockridge O (1995)
Subunit Association and Stabilization of Butyrylcholinesterase (BChE)
In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.: 129

Clery C, Heiber-Langer I, Channac L, David L, Balny C, Masson P (1995)
Substrate dependence of amiloride- and soman-induced conformation changes of butyrylcholinesterase as evidenced by high-pressure perturbation
Biochimica & Biophysica Acta 1250: 19

Clery C, Renault F, Masson P (1995)
Pressure-induced molten globule state of cholinesterase
FEBS Letters 370: 212

Clery C, Bec N, Balny C, Mozhaev VV, Masson P (1995)
Kinetics of butyrylcholinesterase in reversed micelles under high pressure
Biochimica & Biophysica Acta 1253: 85

Fournier D, Maturano M, Gagnoux L, Ziliani P, Pertuy C, Pralavorio M, Bride JM, Elmarbouh L, Klaebe A, Masson P (1995)
Insect Acetylcholinesterase and Resistance to Insecticides
In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.: 149

Lebleu M, Clery C, Masson P, Reuveny S, Marcus D, Velan B, Shafferman A (1995)
Denaturation of Recombinant Human Acetylcholinesterase
In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.: 131

Masson P, Clery C (1995)
Pressure Effects on Structure and Activity of Cholinesterase
In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.: 113

Masson P, Froment MT, Bartels CF, Lockridge O (1995)
Peripheral Anionic Site of Wild-Type and Mutant Human Butyrylcholinesterase
In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.: 230

Kris M, Jbilo O, Bartels CF, Masson P, Rhode S, Lockridge O (1994)
Endogenous butyrylcholinesterase in SV40 transformed cell lines: COS-1, COS-7, MRC-5 SV40, and WI-38 VA13
In Vitro Cellular & Developmental Biology Animal 10: 680

Masson P, Gouet P, Clery C (1994)
Pressure and propylene carbonate denaturation of native and aged phosphorylated cholinesterase
Journal of Molecular Biology 238: 466

Masson P, Froment MT, Sorenson RC, Bartels CF, Lockridge O (1994)
Mutation His322Asn in human acetylcholinesterase does not alter electrophoretic and catalytic properties of the erythrocyte enzyme
Blood 83: 3003

Curtil C, Masson P (1993)
[Aging of cholinesterase after inhibition by organophosphates].
Ann Pharm Fr 51: 63

Masson P, Adkins S, Gouet P, Lockridge O (1993)
Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant
Journal of Biological Chemistry 268: 14329

Clery C, Masson P, Heiber-Langer I, Balny C (1992)
Soman inhibition of butyrylcholinesterase in the presence of substrate: pressure and temperature perturbations
Biochimica & Biophysica Acta 1159: 295

Masson P, Adkins S (1992)
Expression and Refolding of Functional Human Butyrylcholinesterase from E. Coli
In Multidisciplinary approaches to cholinesterase functions - Proceedings of Fourth International Meeting on Cholinesterases (Shafferman, A. and Velan, B., Eds) Plenum Press, New York: 49

Arpagaus M, Chatonnet A, Masson P, Newton M, Vaughan TA, Bartels CF, Nogueira CP, La Du BN, Lockridge O (1991)
Use of the polymerase chain reaction for homology probing of butyrylcholinesterase from several vertebrates
Journal of Biological Chemistry 266: 6966

Arpagaus M, Vaughan TA, La Du BN, Lockridge O, Masson P, Chatonnet A, Newton M, Taylor P (1991)
Poster: Use of the polymerase chain reaction for homology probing of butyrylchoIinesterase (BCHE) in several animal species
In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC: 194

Aslanian D, Grof P, Masson P, Taylor P, Bon S, Chatel JM, Massoulie J (1991)
Poster: A comparative raman spectroscopic study of cholinesterases
In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC: 56

Aslanian D, Grof P, Bon S, Masson P, Negrerie M, Chatel JM, Balkanski M, Taylor P, Massoulie J (1991)
A comparative Raman spectroscopic study of cholinesterases
Biochimie 73: 1375

Masson P (1991)
Molecular Heterogeneity of Human Plasma Cholinesterase
In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC: 42

Masson P, Clery C, Huchet D (1991)
Poster: Stability of native and organophosphate-inhibited butyry1cholinesterase under high pressure
In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC: 275

Masson P, Froment MT, Audras JC, Renault F (1991)
Poster: Molecular characterization of the C5 human plasma cholinesterase variant
In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC: 60

Masson P (1991)
Structural and functional investigations of cholinesterases by means of affinity electrophoresis
Cellular Molecular Neurobiology 11: 173

Checler F, Grassi J, Masson P, Vincent JP (1990)
Monoclonal antibodies allow precipitation of esterasic but not peptidasic activities associated with butyrylcholinesterase
Journal of Neurochemistry 55: 750

Masson P, Chatonnet A, Lockridge O (1990)
Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2)
FEBS Letters 262: 115

Masson P, Balny C (1990)
Conformational plasticity of butyrylcholinesterase as revealed by high pressure experiments
Biochimica & Biophysica Acta 1041: 223

Masson P (1989)
A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate
Biochimica & Biophysica Acta 998: 258

Masson P, Balny C (1988)
Effects of high pressure on the single-turnover kinetics of the carbamylation of cholinesterase
Biochimica & Biophysica Acta 954: 208

Masson P, Laurentie M (1988)
Stability of butyrylcholinesterase: thermal inactivation in water and deuterium oxide
Biochimica & Biophysica Acta 957: 111

Ferro A, Masson P (1987)
Kinetic evidence for thermally induced conformational change of butyrylcholinesterase
Biochimica & Biophysica Acta 916: 193

Chatonnet A, Masson P (1986)
Is the peptidase activity of highly purified human plasma cholinesterase due to a specific cholinesterase isoenzyme or a contaminating dipeptidylaminopeptidase?
Biochimie 68: 657

Masson P, Goasdoue JL (1986)
Evidence that the conformational stability of 'aged' organophosphate-inhibited cholinesterase is altered
Biochimica & Biophysica Acta 869: 304

Masson P, Balny C (1986)
Thermodynamic arguments for temperature-induced cryptic conformational change of human plasma cholinesterase
Biochimica & Biophysica Acta 874: 90

Chatonnet A, Masson P (1985)
Study of the peptidasic site of cholinesterase: preliminary results
FEBS Letters 182: 493

Masson P, Marnot B (1985)
[Affinity electrophoresis in polyacrylamide gel. Influence of the concentration in the gel on the apparent affinity of cholinesterase for an anionic ligand site]. [French]
Journal of Chromatography 328: 135

Chatonnet A, Masson P (1984)
[The peptidase site of butyrylcholinesterase is distinct from the esterase site]. [French]
Comptes Rendus de l Academie des Sciences 299: 529

Masson P, Marnot B, Lombard JY, Morelis P (1984)
Poster 84. Electrophoretic studies of the aged soman-inhibited butyrylcholinesterase
In: Cholinesterases, fundamental and applied aspects : proceedings of the Second International Meeting on Cholinesterases (Brzin M, Barnard EA, Sket D, Eds) De Gruyter:

Masson P, Marnot B, Lombard JY, Morelis P (1984)
[Electrophoretic study of aged butyrylcholinesterase after inhibition by soman]. [French]
Biochimie 66: 235

Masson P, Vallin P (1983)
[Possibilities of study of the human plasma cholinesterase variants by affinity electrophoresis]. [French]
Journal of Chromatography 273: 289

Masson P, Privat de Garilhe A, Burnat P (1982)
[Multiple molecular forms of human plasma butyrylcholinesterase. II.-Study of the C1, C3 and C4 components by means of affinity electrophoresis (author's transl)]. [French]
Biochimica & Biophysica Acta 701: 269

Masson P, Sussmilch A, Charlet JP (1980)
[Purification of butyrylcholinesterase from human plasma]. [French]
Comptes Rendus de l Academie des Sciences 290: 857

Masson P (1979)
[Multiple molecular forms of human plasma butyrylcholinesterase. I. Apparent molecular parameters and broad pattern of the quaternary structure (author's transl)]. [French]
Biochimica & Biophysica Acta 578: 493

Masson P, Germani F, Plasse M (1979)
[Frequency of locus E1 variants of plasma butyrylcholinesterase in a French population]. [French]
Comptes Rendus de l Academie des Sciences 289: 537

Masson P (1979)
[Determination of free electrophoretic mobility of proteins by gradient polyacrylamide electrophoresis]. [French]
Journal of Chromatography 169: 386